Filter posts

Oncology Clinical Trials - Secrets of Success

At last year’s BIO CEO & Investor Conference, BIO and BioMedTracker presented data showing that …

BIO CEO 2012 Opening Remarks

The 14th Annual BIO CEO & Investor Conference started with a busy turnout Monday at …

A Very Big BTK January

We all heard reports that January was a great start to 2012 for the stock …

Reviewing the drug class of 2011

The drug class of 2011 was larger than the past few graduating classes. We count …

Venture Capital increases in 2011, but...

The National Venture Capital Association (NVCA) has released their 4Q 2011 numbers for biotech venture …

Sizing up the NBI in 2011

How did the Nasdaq Biotechnology Index (NBI) perform in 2011 relative to other sectors? Second …

IPO Update - Jan 2012

2011 ended quietly for the US biotech IPO market. It has now been almost two …

Where's the Deal?

With only two weeks to go in 2011 it is looking like a five year …

Just how big is $11 Billion? GILD Acquires VRUS

Seeing the markets open down 2% or more on a Monday morning feels like “business …

Public Exits and Virtual Biotechs - Dreams or Reality?

Here at the 10th Annual BIO Investor Forum, investors and CEOs are debating “all the …